Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study - Top-Institutions - MDSpire

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

  • By

  • Jong Hyuk Lee

  • Ho Cheol Kim

  • Kyu-Won Jung

  • Chang Min Choi

  • June 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Korea Central Cancer Registry
    Korea Central Cancer Registry

    Seoul, South Korea

    Key Differentiators

    • Oncology

  • #2

    52 hospitals across South Korea
    52 hospitals across South Korea

    Various, South Korea

    Key Differentiators

    • Oncology

  • #3

    North Estonia Medical Centre (NEMC) Foundation
    North Estonia Medical Centre (NEMC) Foundation

    Tallinn, Estonia

    Key Differentiators

    • Oncology

  • #4

    Stanford NSCLC Radiogenomics
    Stanford NSCLC Radiogenomics

    Stanford, California

    Key Differentiators

    • Oncology

Original Source(s)

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

  • by Jong Hyuk Lee, Ho Cheol Kim, Kyu-Won Jung, Chang Min Choi

  • June 8, 2026

Related Content

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study

Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression

Case report: A challenging case of stage IVB mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder treated with extended radical resection including portal vein reconstruction